Twist Bioscience Net Worth

Twist Bioscience Net Worth Analysis

Twist Bioscience Target Price Consensus

Twist Bioscience Target Price Projection

Twist Bioscience's current and average target prices are 35.17 and 48.38, respectively. The current price of Twist Bioscience is the price at which Twist Bioscience Corp is currently trading. On the other hand, Twist Bioscience's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Twist Bioscience Corp and the information provided on this page.

Know Twist Bioscience's Top Institutional Investors

Note, although Twist Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Twist Bioscience's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.11 B.

Project Twist Bioscience's profitablity

The company has Profit Margin (PM) of (0.55) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.45.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Twist Bioscience's management efficiency

Twist Bioscience Corp has return on total asset (ROA) of (0.1504) % which means that it has lost $0.1504 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3822) %, meaning that it created substantial loss on money invested by shareholders. Twist Bioscience's management efficiency ratios could be used to measure how well Twist Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2025. Return On Capital Employed is likely to drop to -0.38 in 2025. Non Current Liabilities Total is likely to gain to about 86.5 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 49 M in 2025.

Twist Bioscience Corporate Filings

Twist Bioscience time-series forecasting models is one of many Twist Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Twist Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Twist Bioscience Earnings Estimation Breakdown

The calculation of Twist Bioscience's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Twist Bioscience is estimated to be -0.451875 with the future projection ranging from a low of -0.6125 to a high of -0.335. Please be aware that this consensus of annual earnings estimates for Twist Bioscience Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.

Twist Bioscience Earnings Projection Consensus

Twist Bioscience Earnings per Share Projection vs Actual

Actual Earning per Share of Twist Bioscience refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Twist Bioscience Corp predict the company's earnings will be in the future. The higher the earnings per share of Twist Bioscience, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Twist Bioscience Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Twist Bioscience, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Twist Bioscience should always be considered in relation to other companies to make a more educated investment decision.

Twist Quarterly Analyst Estimates and Surprise Metrics

Twist Bioscience Corporate Management

Additional Tools for Twist Stock Analysis